Literature DB >> 25907470

Development and application of an indirect ELISA for the detection of antibodies to novel duck reovirus.

Tao Yun1, Haipeng Chen2, Bin Yu1, Cun Zhang3, Liu Chen1, Zheng Ni1, Jionggang Hua1, Weicheng Ye1.   

Abstract

A novel duck reovirus (N-DRV) disease emerged in China in 2000 and it has become an epidemic genotype. A test for detection of virus-specific antibodies in serum samples would be useful for epidemiological investigations. Currently, Currently, serological assays for N-DRV diagnosis are not available. A test for detection of virus-specific antibodies in serum samples would be useful for epidemiological investigations. In this study, a highly sensitive and specific indirect enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to N-DRV was developed. The outer capsid (σC) of N-DRV was cloned and expressed in Escherichia coli as a coating antigen. The antigen concentration and serum dilution were optimized using a checkerboard titration. Furthermore, the specificity of σC-ELISA assay was confirmed by cross checking with other duck viral pathogens. In comparison with the western blot, the sensitivity and specificity of the σC-ELISA was 92.6% and 88.9%, respectively, and agreement of two tests was excellent with κ value of 0.786 (p < 0.05). A serological survey was performed using the assay on serum samples from different age and species of duck flocks in the Zhejiang and Jiangsu Province, China. The seropositive rate of the 1209 serum samples was 57.7%. In conclusion, the developed σC-ELISA assay is a very specific and sensitive test that will be useful for large-scale serological survey in N-DRV infection and monitoring antibodies titers against N-DRV.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Indirect ELISA; Novel duck reovirus (N-DRV); Serological survey; σC protein

Mesh:

Substances:

Year:  2015        PMID: 25907470     DOI: 10.1016/j.jviromet.2015.04.012

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  7 in total

1.  Comparative proteomic analysis revealed complex responses to classical/novel duck reovirus infections in Cairna moschata.

Authors:  Tao Yun; Jionggang Hua; Weicheng Ye; Bin Yu; Liu Chen; Zheng Ni; Cun Zhang
Journal:  Sci Rep       Date:  2018-07-04       Impact factor: 4.379

2.  Establishment of a simultaneous detection method for ten duck viruses using MALDI-TOF mass spectrometry.

Authors:  Ning Liu; Lei Wang; Gaozhe Cai; Dabing Zhang; Jianhan Lin
Journal:  J Virol Methods       Date:  2019-08-17       Impact factor: 2.014

3.  The phosphoproteomic responses of duck (Cairna moschata) to classical/novel duck reovirus infections in the spleen tissue.

Authors:  Tao Yun; Jionggang Hua; Weicheng Ye; Zheng Ni; Liu Chen; Cun Zhang
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379

4.  Development of a reverse transcription loop mediated isothermal amplification assay for the detection of Mouse reovirus type 3 in laboratory mice.

Authors:  Taofeng Lu; Lingyun Tao; Haibo Yu; Hui Zhang; Yanjun Wu; Shuguang Wu; Jie Zhou
Journal:  Sci Rep       Date:  2021-02-10       Impact factor: 4.379

5.  DDX1 from Cherry valley duck mediates signaling pathways and anti-NDRV activity.

Authors:  Huihui Zhang; Xingdong Song; Tianxu Li; Jinchao Wang; Bin Xing; Xinyu Zhai; Jinjian Luo; Xiaofang Hu; Xiaolan Hou; Liangmeng Wei
Journal:  Vet Res       Date:  2021-01-20       Impact factor: 3.683

6.  Intergrated Transcriptomic and Proteomic Analysis Revealed the Differential Responses to Novel Duck Reovirus Infection in the Bursa of Fabricius of Cairna moschata.

Authors:  Tao Yun; Jionggang Hua; Weicheng Ye; Zheng Ni; Liu Chen; Yinchu Zhu; Cun Zhang
Journal:  Viruses       Date:  2022-07-25       Impact factor: 5.818

7.  A TaqMan-based real-time PCR assay for specific detection of novel duck reovirus in China.

Authors:  Shuai Zhang; Weihua Li; Xiaodong Liu; Xudong Li; Bin Gao; Youxiang Diao; Yi Tang
Journal:  BMC Vet Res       Date:  2020-08-25       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.